Showing results (211-220 of 344) with videos related to

Sort By:
Pageof 35
Journal of Molecular and Cellular Cardiology|October 4, 2005
Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cellsCarmen Urbich, Alexandra Aicher, Christopher Heeschen, et al.
Blood|June 30, 2005
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemiaSigal Gery, Adrian F Gombart, William S Yi, et al.
Journal of Thoracic Imaging|February 28, 2007
Coronary CTA: image acquisition and interpretationJosef Matthias Kerl, Lars K Hofmann, Christian Thilo, et al.
Annals of Hematology|July 1, 2008
Combined automated cell and flow cytometric analysis enables recognition of persistent polyclonal B-cell lymphocytosis (PPBL), a study of 25 patientsM Schmidt-Hieber, T Burmeister, A Weimann, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 26, 2007
Genomic imprinting of insulin-like growth factor 2 (IGF-2) in chronic synovitisB Möller, G Kerschbaumer, M Komor, et al.
Annals of Hematology|June 10, 1998
Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicinG Seipelt, W K Hofmann, H Martin, et al.
European Journal of Haematology|June 8, 1999
Megakaryocytic growth in patients with refractory anemia is suppressed by treatment with interferon alphaW K Hofmann, U Kalina, G Seipelt, et al.
The Journal of Biological Chemistry|April 3, 1999
Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinaseM Thome, F Martinon, K Hofmann, et al.
Molecular Syndromology|December 6, 2011
Unmasking of a Recessive SCARF2 Mutation by a 22q11.12 de novo Deletion in a Patient with Van den Ende-Gupta SyndromeM F Bedeschi, L Colombo, F Mari, et al.
Anticancer Research|September 2, 1999
Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseasesU Hasholzner, P Stieber, A Zimmermann, et al.
Pageof 35